This is the beginning of many introductions to the whole marketing area where power is scarce and coal is everywhere. They have the capital now and I do not think the powers in China especially are going to delay and paper work SYMX to death anymore as the air in China is terrible. I have no doubt new projects will begin by the Q3 at the latest and a lot will be financed locally. Robert Rigdon has done a great job righting the company and as long time shareholders e know they are in the right place at the right time. And it is serendipidous that Fukashima actually helps!
I have never looked at it that way having been a victim of high through put screening for compounds that take years and actually yield few winners. Designing a molecule has some interesting attributes that I find better than what they used to do. Again, they have only 1 deal with SNY that did yield very good data. I think they understand the biology of cancer very well and they get all the looks from Cancer Care Centers of America. Again, their CEO is flawed and arrogant with very little in communication skills to the shareholders. I have seen him present to investors and he is clueless as to who he is speaking.
They have huge flaws. Bad management, burning too much capital of drugs similar to 121.
MM 398 has a good chance and could well fund this company until the higher technology kicks in. My feeling is the off label use of 398 will be greater than the pancreatic disease, and that is why they are doing several other trials in many indications.
I guess that is what makes markets. This price is pretty cheap for the next few months.
If 398 fails, I do not think they would be dead. I still have hopes or network biology and the worker bees that run it.
Over 300,000 shares. Me thinks the progress in China is growing and the word coal is no longer whispered.
With Japan mothballing all their nuke plants, they will import a ton of coal and look for different sources of energy. They can tap into a volcano right?
Sentiment: Strong Buy
You should get news before 5/17...But the May series has almost nothing outstanding. But June?? Holy smoke. The covered writes are great returns. And that is where some of the short interest comes from as well as the converts. Too many folks here expect a short squeeze on good 398 data and that is just not going to happen. Good 398 data will bump the stock to $10. And off label use of 398? That is the bigger enchilada. Why do you think they are using it in other indicactive trials, like colorectal?
Ever think of rolling your May calls into June??
Denise..Sell your shares and go invest elsewhere. You like a lot of others are buying low dollar biotech and device shares hoping the masses come over and run it up so you can sell. That is not going to happen here. This is a June 17th-20th event.
Oh and you have not lost a cent until you sell.
Sorry big guy but I am long. I do not like management, I think there are a lot of hype types on this board, but I have been with MACK since it was private and have a very good understanding of network biology which is the essence of MACK. The CEO is totally useless as he has promised too much and delivered very little. I would own more except for the management. I am not sure where you are coming from regarding your constant trashing the company but just let it play out. Three or four weeks and we will all get our answers. A lot of those boys have their net worth tied up in MACK. Sit back and relax and we will all get the data together.
200 day moving average is 1.61..That is the first stop..then it fills the gap at $1.40..then you buy it. Lot of small specks bailing out..This is real selling though small as no one will short down here..
Good analysis..but two things. It is invasive surgery and while it will be outpatient ( insurers love that ) you still have to tranquilize the rhinos. Secondly, if it takes off, short the company that makes Cheetos!
Oh, ARNA and VVUS are not competitors. Phen-Fen still have them in limbo and serious obesity will not be cured with a pill. Ever! Our competition is out there somewhere but it will be evident long after we are taken out.
It is always good management to have a large authorization. Let us say they get the approval and the stock goes to $8.00 for instance. If they are going to manufacture and market they will need facilities and bodies so the could sell 10 million shares and get started. What if they found a small manufacturing company like the one that presently makes the device and they buy them. It is good to have a stock to use as a currency in acquisitions. They are doing the prudent thing. They will NOT issue shares here as they do not have to. Upon approval the whole game changes and it looks like they are preparing in every way for every eventuality. Good management does that.
Will the individual who paid $5.14 for 700 shares after hours please stand up! The stock spends the day getting trashed along with the whole biotech arena, trades 22,000 shares after hours at $4.85 and then the last trade of the day 700 shares mysteriously trade at $5.14. Did your mother drop you on your head when you were a tot? Gotta love the morons loose in this market don't you?
Did you lose so much money in MACK that you have to post every millisecond? Get a life pal. You go short and then come back when 398 fails and we will applaud. Other than that #$%$.
They should put me on the Board. I have a finance background and their board is lacking that talent.
Sales are easy and from my view I think someone else will do it for them.
I love your enthusiasm and I am a large owner of this stock, but VBLOC is not like taking a pill. A lot of obese people ( your 600 pounders ) are obviously candidates for this procedure, but getting the masses in the door and paying for it are two different things. The initial start up costs for this device and the marketing of it will be substantial. You have to have peer reviews and medical consultations which will take time. This company does not have the capital for this. I am pretty confident in the approval but know that the process will take a lot longer. This is not an Apple I Phone. I have yet to hear the CEO impress upon the market what his game plan is following approval to a point where I personally am comfortable. I did mention I thought the cost of the device they quoted you was high enough to bring in competition. I have not examined their patent estate and would really like to know if you can comment on that. And the matter of the FDA pushing VBLOC? The FDA does not push anything. They are regulators not IR/PR operations. They are there to protect the public not advertise for the client. As an alternative to bariatric surgery I can see that argument, but the masses with a BMI over 40? I do not see them crashing down the door to get an invasive procedure until it has been proven effective in the market. Capital and time are two ingredients ETRM needs to acquire. I think this stock has to potential to rise 10 fold from here but I think management needs a cogent game plan to reach that goal.
These are my opinions as a shareholder.